Alpine Immune Sciences (ALPN) Financials

$64.97

$0.00 (0.00%)

As on 20-May-2024 09:30EDT

Market cap

$4,457 Mln

Revenue (TTM)

$57 Mln

P/E Ratio

--

P/B Ratio

12.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	56.52	58.88	30.06	23.44	9.34	1.74
Cost of Revenue	0.58	0.58	0.60	0.62	27.19	35.85
Gross Profit	55.94	58.30	29.47	22.82	-17.85	-34.11
Operating Expenses	107.58	102.55	88.21	73.30	38.08	45.31
Operating Profit (EBIT)	-51.35	-44.25	-58.15	-49.86	-28.75	-43.57
Other Income	2.53	--	3.19	0.26	1.58	2.06
Profit before Tax	-36.73	-32.08	-55.43	-50.42	-27.95	-41.85
Provision for Tax	0.07	0.10	2.33	-0.09	-0.01	0.68
Profit after Tax (Net Income)	-36.84	-32.18	-57.76	-50.33	-27.94	-42.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-13.16	--	-57.76	-50.33	-27.94	-41.85

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	332.70	327.94	179.42	120.90	62.16	29.47
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.70	11.89	49.27	65.22	40.77	15.94
Current Liabilities	32.24	41.98	58.00	69.78	41.17	8.68
Total Liabilities	405.88	381.81	286.69	255.90	144.09	54.09

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	65.40	51.78	45.69	63.89	36.99	11.79
Current Assets	308.25	330.03	240.99	192.01	107.10	42.30
Total Assets	405.88	381.81	286.69	255.90	144.09	54.09
Total Debt*	9.66	9.91	14.22	19.63	22.60	16.36
Net Current Assets	276.01	288.05	183.00	122.24	65.93	33.62

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-79.01	-43.75	-15.25	30.08	-35.35
Cash Flow from Investing Activities	--	--	-113.35	-52.48	-72.82	16.76
Cash from Financing Activities	--	165.12	102.69	100.76	61.38	24.26
Net Cash Inflow / Outflow	--	--	-54.41	33.04	18.65	5.67

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.67	-0.64	-1.75	-2.01	-1.33	-2.36
Cash EPS ($)	--	-0.63	-1.73	-1.99	-1.30	-2.34
Adjusted Book Value ($)	--	6.56	5.44	4.84	2.96	1.64
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.58	-1.33	-0.61	1.43	-1.96
Free Cash Flow per Share ($)	--	-1.59	-1.34	-0.61	1.39	-2.01

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-12.11	-34.57	-44.68	-42.79	-89.90
ROE (%)	-14.90	-12.69	-38.47	-54.99	-60.98	-114.86
ROA (%)	-10.16	-9.63	-21.29	-25.17	-28.20	-78.07
EBIT Margin (%)	-81.38	-75.16	-193.41	-212.68	-307.97	-2,504.25
Net Margin (%)	-62.38	-54.66	-173.69	-212.39	-256.02	-1,119.32
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	118.89	0.96	0.28	1.51	4.36	1.47
EBIT Growth (%)	30.60	23.90	-16.62	-73.43	34.02	-21.99
Net Profit Growth (%)	39.30	44.28	-14.76	-80.15	34.31	-16.57
EPS Growth (%)	62.58	0.63	0.13	-0.51	0.44	0.09
Book Value Growth (%)	47.18	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-29.61	-4.20	-6.88	-9.47	-1.63
Price / Book Value	12.87	2.91	1.35	2.86	4.26	2.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-124.26	-14.55	-0.35	-4.10	-6.68	-1.08
Close Price ($)	39.64	19.06	7.35	13.85	12.60	3.84
High Price ($)	42.88	20.94	14.40	15.14	16.37	8.24
Low Price ($)	6.71	6.40	4.82	7.87	2.05	2.25
Market Cap ($ Cr)	4,456.78	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.03	0.08	0.16	0.36	0.55
Short term debt to equity ratio	0.00	0.00	0.02	0.04	0.05	0.01
Current Ratio	9.56	7.86	4.16	2.75	2.60	4.87
Quick Ratio	9.56	7.87	4.16	2.76	2.61	4.95
Interest Coverage	-162.99	-451.53	-122.16	-61.10	-37.10	-128.92

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	0.96	1.27	2.36	108.02	4.16	39.43
Asset Turnover	0.16	0.18	0.11	0.12	0.09	0.03
Receivable days	--	4.52	158.13	200.29	21.01	96.88
Inventory Days	--	-153.46	-195.78	-209.43	-7.21	-6.99
Payable days	--	2,498.09	2,335.58	1,157.90	14.28	16.60
Cash Conversion Cycle	--	-2,647.03	-2,373.23	-1,167.04	-0.48	73.28

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.